Octagon Capital Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Octagon Capital Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-199,876	Closed	-$2.26M	–	37
2022 Q2	$2.26M	Sell	199,876 -849,815	-81%	-$10.2M	0.6%	15
2022 Q1	$17M	Hold	1,049,691	–	–	3.69%	10
2021 Q4	$49.7M	Buy	1,049,691 +285,230	+37%	+$17.1M	9.68%	3
2021 Q3	$55.4M	Sell	764,461 -178,695	-19%	-$12.9M	13.64%	1
2021 Q2	$79.2M	Buy	943,156 +413,106	+78%	+$27.3M	16.4%	2
2021 Q1	$25.7M	Buy	530,050 +75,500	+17%	+$4.1M	9.68%	1
2020 Q4	$21.4M	Buy	+454,550	New	+$17.9M	7.43%	2

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Octagon Capital Advisors's NBP Position: Q3 2022 in Review

Octagon Capital Advisors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 199,876 shares — an estimated $2.26M sold.

Octagon Capital Advisors first reported a position in NBP in Q4 2020 and held it in 7 quarters. The position peaked at $79.2M in Q2 2021. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

Octagon Capital Advisors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Octagon Capital Advisors sold 199,876 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $2.26M.
Octagon Capital Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 7 quarters.
Octagon Capital Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $79.2M in Q2 2021.
75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Octagon Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.